TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06017622: Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression

Sponsor: Anebulo Pharmaceuticals · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 36 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$465,600

Rescue Site Savings

+$310,400

Unlock Full NCT06017622 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06017622 Rescue Dossier →